15 May 2002
Proinflammation: a common denominator or initiator of different pathophysiological disease processes
Tobias Esch, George StefanoMed Sci Monit 2002; 8(5): HY1-9 :: ID: 420856
Abstract
Proinflammation is a widespread phenomenon. It has an association withthe stress (patho)physiology and is connected with various diseases. Recently, it has been discussedif proinflammation may represent a common (pre)condition in different disease states. Evidence for acommon proinflammatory pattern in a variety of diseases is analyzed. Proinflammatory (pre)conditionsand immune response patterns serve as a common modality in a number of clinically separate diseases.Here, nitric oxide pathways often play a significant role as well. On molecular basis, proinflammationpotentially illustrates a common denominator and/or an initiator. Like stress, proinflammation seemsto be a crucial autoregulatory concept. It normally serves a positive biological goal: Proinflammatoryactivities, e.g., are initiated to overcome infection or invasion of potentially deleterious biologicalagents (bacteria, viruses, parasites etc.). While fighting invasion, proinflammation usually shortensbiological 'battles' and therefore ameliorates disease-related detrimental or subjectively unpleasingphenomena. However, proinflammation has beneficial and deteriorating capacities and may yet exert detrimentaleffects. This is especially true, when the fine balance between the different immune response pathways,between anti- and proinflammatory mechanisms, can not be kept. This may occur when a challenge becomesoverwhelming or when patterns of a chronic (patho)physiological activity are presented. Thus, proinflammationmay represent a relatively unspecific, overlapping/ analogous state, underlying various clinical diseasemanifestations.
Keywords: Autoimmune Diseases, Cytokines, Disease, Immune System, Models, Biological, Nitric Oxide, Research Support, Non-U.S. Gov, Research Support, U.S. Gov
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952